Randomized Phase III Study of Exatecan and Gemcitabine Compared With Gemcitabine Alone in Untreated Advanced Pancreatic Cancer - Concepedia

Concepedia

Publication | Open Access

Randomized Phase III Study of Exatecan and Gemcitabine Compared With Gemcitabine Alone in Untreated Advanced Pancreatic Cancer

DOI Full Paper Access

277

Citations

13

References

2006

Year

Ghassan K. Abou‐Alfa, Richard Létourneau, Graydon Harker, Manuel Modiano, Herbert I. Hurwitz, N. Simon Tchekmedyian, Kevie Feit, Judie Ackerman, Robert L. De Jager, S. Gail Eckhardt,

Journal of Clinical Oncology

Abstract

Exatecan plus gemcitabine was not superior to gemcitabine alone with respect to overall survival in the first-line treatment of advanced pancreatic cancer.

References

	Year	Citations

Page 1